Home > Healthcare > Drug Device Combination > Therapeutic Systems > Cold Pain Therapy Market
- Report ID: GMI10118
- Published Date: Jul 2024
- Report Format: PDF
Cold Pain Therapy Market Size
Cold Pain Therapy Market size was valued at around USD 1.9 billion in 2023 and is estimated to grow at 4.8% CAGR from 2024 to 2032. The increasing prevalence of orthopedic diseases significantly contributes to the growth of the market. With the rise in conditions such as osteoarthritis, rheumatoid arthritis, and sports injuries, there is a growing need for effective, non-invasive pain management solutions.
For instance, according to the Centers for Disease Control and Prevention (CDC), 23% of all adults in the U.S. have arthritis, which equates to more than 54 million people. The prevalence of osteoarthritis is expected to increase with the aging population. Cold pain therapy meets this demand, providing relief and supporting recovery, which drives market expansion.
Report Attribute | Details |
---|---|
Base Year: | 2023 |
Cold Pain Therapy Market Size in 2023: | USD 1.9 Billion |
Forecast Period: | 2024 - 2032 |
Forecast Period 2024 - 2032 CAGR: | 4.8% |
2032 Value Projection: | USD 3 Billion |
Historical Data for: | 2021 - 2023 |
No. of Pages: | 100 |
Tables, Charts & Figures: | 177 |
Segments covered: | Product Type, Application, Distribution Channel and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|
Download Free Sample
Cold pain therapy is a treatment method that involves the application of cold substances or devices to the body to reduce pain, inflammation, and swelling. It is commonly used for acute injuries, chronic pain, and post-surgical recovery. The therapy works by constricting blood vessels, which decreases blood flow to the affected area, thereby reducing inflammation and numbing nerve endings to alleviate pain.
Authors: Mariam Faizullabhoy, Gauri Wani
Frequently Asked Questions (FAQ) :
Cold pain therapy industry size was worth USD 1.9 billion in 2023 and will grow at 4.8% CAGR between 2024 and 2032, driven by the rising prevalence of sports injuries and musculoskeletal disorders along with the increasing demand for effective pain management solutions.
The musculoskeletal disorders segment recorded USD 777.4 million in 2023, primarily due to the high prevalence of conditions like arthritis, back pain, and tendonitis and increasing awareness of the benefits in reducing inflammation and accelerating recovery.
North America cold pain therapy industry size was USD 676.2 million in 2023, propelled by the high prevalence of sports injuries and musculoskeletal disorders, advanced healthcare infrastructure, coupled with significant investments in R&D of innovative cold therapy products.
Bird & Cronin, LLC, Breg, Inc., Cardinal Health, Compass Health Brands, Hisamitsu Pharmaceutical Co., Inc., Johnson & Johnson Consumer Inc., Performance Health, Polar Products Inc., Rapid Aid, Romsons Group of Industries, and Sanofi among others.
Cold Pain Therapy Market Scope
Buy Now
Premium Report Details
- Base Year: 2023
- Companies covered: 15
- Tables & Figures: 177
- Countries covered: 23
- Pages: 100